Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to Italy

The forecast for the import of ambergris, civet, and musk for pharmaceutical use into Italy shows a steady increase in value over the 2024-2028 period. The series, starting with a value of $11.621 million in 2024 and reaching $13.003 million by 2028, indicates a consistent upward trend.

The year-on-year growth rates from 2024 to 2028 reflect a positive trajectory:

• 2024-2025: Approximate 3.1% increase
• 2025-2026: Approximate 2.9% increase
• 2026-2027: Approximate 2.8% increase
• 2027-2028: Approximate 2.7% increase

The compound annual growth rate (CAGR) over the forecasted five-year period is an estimated 2.8% annually. The consistent growth reflects increasing demand and potential expansion in pharmaceutical applications.

Future trends to watch include potential regulatory changes impacting imports, innovations in synthetic alternatives, and shifts in consumer preferences toward natural ingredients, which could further drive demand. Additionally, monitoring the supply chain for these ingredients will be crucial, given their reliance on animal-derived sources.